CSIR, HP launch cloud-enabled eHealth initiative

Updated on 12 December 2012

The eHC solution addresses these challenges. It is a solution that is housed in a standard shipping container, which can be quickly transported to remote areas of the country by air, rail or by land transport. It is affordable and easily deployable as compared to brick and mortar alternatives and is equipped with basic cloud-integrated diagnostic equipment, a telemedicine studio, laboratory and a pharmacy. Paramedics can staff the eHC, with specialist medical interventions provided through remote medical consultation. This minimizes the need for on-site skilled doctors in isolated locations. Remote monitoring of the eHC functioning and its equipment is done through the eHC Health Cloud, minimizing absenteeism and equipment downtimes.

The eHC Health Cloud integrates the process of healthcare delivery and health data collection. This centralized patient information sets the platform for data-driven research such as disease surveillance by tracking disease patterns and risk factors. The health profile of the region as well as monitoring of the daily usage of the eHC is enabled by an integrated eHC dashboard, providing comprehensive yet digestible analytics that will help health policymakers.

"HP is collaborating with government health authorities and organizations to reinvent medical processes, modernize systems, and develop solutions that dramatically expand access, improve healthcare, and save lives. The eHealth Center is an example of our commitment to social innovation and to the government's priorities, reiterating our belief of shared value," commented Mr Neelam Dhawan, Vice President and General Manager, Enterprise Group and Country Managing Director, HP India.

The first eHC at Chausala is operated by and remotely connected to Maharaja Agrasen Medical College (MAMC). The O P Jindal Gramin Jan Kalyan Sansthan facilitated access and delivery of the solution in Chausala village as well as the necessary social engineering.

Previous 1 2 Next

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X